Although previous reports have shown that the TGF-β pathway is critical for CML LSC survival[45-47], it also has been suggested that TGF-β has a dual role in tumor progression, acting as a tumor suppressor in the very early stages of tumorigenesis[48, 49]. Here, TGFB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.